Human HGF Antibody

Catalog # Availability Size / Price Qty
AF-294-NA
AF-294-SP
Detection of Recombinant Human HGF by Western Blot.
5 Images
Product Details
Citations (38)
FAQs
Supplemental Products
Reviews (1)

Human HGF Antibody Summary

Species Reactivity
Human
Specificity
Detects human HGF in direct ELISAs and Western blots. In direct ELISAs and Western blots, less than 5% cross-reactivity with recombinant mouse HGF is observed. In Western blots, no cross-reactivity with recombinant canine HGF is observed.
Source
Polyclonal Goat IgG
Purification
Antigen Affinity-purified
Immunogen
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human HGF
Gln32-Ser728 (Asp384Asn, Asp416Asn, Leu622Ser, His645Arg, Val678Ile)
Accession # P14210
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Endotoxin Level
<0.10 EU per 1 μg of the antibody by the LAL method.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
0.1 µg/mL
See below
Immunohistochemistry
5-15 µg/mL
See below
Neutralization
Measured by its ability to neutralize HGF-induced IL-11 secretion in the Saos‑2 human osteosarcoma cell line. Hjertner, O. et al. (1999) Blood 94:3883.The Neutralization Dose (ND50) is typically 0.01-0.06 μg/mL in the presence of 3 ng/mL Recombinant Human HGF.

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot Detection of Recombinant Human HGF antibody by Western Blot. View Larger

Detection of Recombinant Human HGF by Western Blot. Western blot shows 25 ng of Recombinant Human HGF (Catalog # 294-HG), Recombinant Mouse HGF (Catalog # 2207-HG) and Recombinant Canine HGF (Catalog # 3386-HG). PVDF Membrane was probed with 0.1 µg/mL of Goat Anti-Human HGF Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-294-NA) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). Specific bands were detected for HGF at approximately 30 and 60 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 3.

Immunohistochemistry HGF antibody in Human Liver by Immunohistochemistry (IHC-P). View Larger

HGF in Human Liver. HGF was detected in formalin fixed paraffin-embedded sections of human liver using 15 µg/mL Goat Anti-Human HGF Antigen Affinity-purified Polyclonal Antibody (Catalog # AF-294-NA) overnight at 4 °C. Tissue was stained with the Anti-Goat HRP-DAB Cell & Tissue Staining Kit (brown; Catalog # CTS008) and counterstained with hematoxylin (blue). View our protocol for Chromogenic IHC Staining of Paraffin-embedded Tissue Sections.

Neutralization IL-11 Secretion Induced by HGF and Neutralization by Human HGF Antibody. View Larger

IL-11 Secretion Induced by HGF and Neutralization by Human HGF Antibody. Recombinant Human HGF induces IL-11 secretion in the Saos-2 human osteosarcoma cell line. The dose-dependent response (orange line) is measured by the Human IL-11 Duoset (Catalog # DY218). Under these conditions, IL-11 secretion elicited by HGF is neutralized (green line) by increasing concentrations of Goat Anti-Human HGF Antigen Affinity-purified Polyclonal Antibod (Catalog # AF-294-NA). The ND50 is typically 0.01-0.06 µg/mL.

Immunohistochemistry-Paraffin Detection of Mouse HGF by Immunohistochemistry-Paraffin View Larger

Detection of Mouse HGF by Immunohistochemistry-Paraffin Characterization of CB42.A) Histology (H&E staining) of CB42 primary tumor. B). Histology (H&E) of CB42 after subcutaneous propagation (CB42P1). C). Immunohistochemical staining for beta -Catenin. D). Immunohistochemical staining for pan Cytokeratin. E). Immunohistochemical staining for HGF. F). Immunohistochemical staining for phospho-Met. Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0105886), licensed under a CC-BY license. Not internally tested by R&D Systems.

Immunohistochemistry-Paraffin Detection of Mouse HGF by Immunohistochemistry-Paraffin View Larger

Detection of Mouse HGF by Immunohistochemistry-Paraffin Characterization of CB42.A) Histology (H&E staining) of CB42 primary tumor. B). Histology (H&E) of CB42 after subcutaneous propagation (CB42P1). C). Immunohistochemical staining for beta -Catenin. D). Immunohistochemical staining for pan Cytokeratin. E). Immunohistochemical staining for HGF. F). Immunohistochemical staining for phospho-Met. Image collected and cropped by CiteAb from the following open publication (https://dx.plos.org/10.1371/journal.pone.0105886), licensed under a CC-BY license. Not internally tested by R&D Systems.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Reconstitute at 0.2 mg/mL in sterile PBS.
Loading...
Shipping
Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: HGF

HGF, also known as scatter factor and hepatopoietin A, is a pleiotropic protein in the plasminogen subfamily of S1 peptidases. It is a multidomain molecule that includes an N-terminal PAN/APPLE-like domain, four Kringle domains, and a serine proteinase-like domain that has no detectable protease activity. Human HGF is secreted as an inactive 728 amino acid (aa) single chain propeptide. It is cleaved after the fourth Kringle domain by a serine protease to form bioactive disulfide‑linked HGF with a 60 kDa alpha  and 30 kDa beta chain. Alternate splicing generates human HGF isoforms that lack the proteinase-like domain and different numbers of the Kringle domains. Human HGF shares 91%‑94% aa sequence identity with bovine, canine, feline, mouse, and rat HGF. HGF binds heparan-sulfate proteoglycans and the widely expressed receptor tyrosine kinase, HGF R/c-MET. HGF-dependent c-MET activation is implicated in the development of many human cancers. HGF regulates epithelial morphogenesis by inducing cell scattering and branching tubulogenesis. HGF induces the upregulation of integrin alpha 2 beta 1 in epithelial cells by a selective increase in alpha 2 gene transcription. This integrin serves as a collagen I receptor, and its blockade disrupts epithelial cell branching tubulogenesis. HGF can also alter epithelium morphology by the induction of nectin-1 alpha  ectodomain shedding, an adhesion protein component of adherens junctions. In the thyroid, HGF induces the proliferation, motility, and loss of differentiation markers of thyrocytes and inhibits TSH-stimulated iodine uptake. HGF promotes the motility of cardiac stem cells in damaged myocardium.

Long Name
Hepatocyte Growth Factor
Entrez Gene IDs
3082 (Human); 15234 (Mouse); 24446 (Rat); 403441 (Canine); 102133907 (Cynomolgus Monkey); 493705 (Feline)
Alternate Names
deafness, autosomal recessive 39; DFNB39; EC 3.4.21; EC 3.4.21.7; fibroblast-derived tumor cytotoxic factor; F-TCF; hepatocyte growth factor (hepapoietin A; scatter factor); Hepatopoeitin-A; Hepatopoietin A; HGF; HGFB; HPTA; HPTAhepatocyte growth factor; lung fibroblast-derived mitogen; Scatter factor; SF; SFhepatopoeitin-A

Product Datasheets

You must select a language.

x

Citations for Human HGF Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

38 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. Increased RAB31 Expression in Cancer-Associated Fibroblasts Promotes Colon Cancer Progression Through HGF-MET Signaling
    Authors: Tang Yang, Huang Zhiheng, Wang Zhanhuai, Xiao Qian, Liu Yue, Ge Xiaoxu et al.
    Frontiers in Oncology
  2. Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6
    Authors: Yvonne Volz, David Koschut, Alexandra Matzke-Ogi, Marina S. Dietz, Christos Karathanasis, Ludovic Richert et al.
    Bioscience Reports
  3. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta 1 signaling
    Authors: Toshinori Ueno, Ayumu Nakashima, Shigehiro Doi, Takeshi Kawamoto, Kiyomasa Honda, Yukio Yokoyama et al.
    Kidney International
  4. Long-term effects of hepatocyte growth factor gene therapy in rat myocardial infarct model
    Authors: Y-N Jin, M Inubushi, K Masamoto, K Odaka, I Aoki, A B Tsuji et al.
    Gene Therapy
  5. c-Met and NF-kB-dependent overexpression of Wnt7a and -7b and Pax2 promotes cystogenesis in polycystic kidney disease.
    Authors: Qin S, Taglienti M, Cai L et al.
    J Am Soc Nephrol.
  6. Hepatic stellate cell–specific knockout of transcriptional intermediary factor 1 gamma aggravates liver fibrosis
    Authors: Eun Ju Lee, Injoo Hwang, Ji Yeon Lee, Jong Nam Park, Keun Cheon Kim, Irene Kim et al.
    Journal of Experimental Medicine
  7. Hepatocyte growth factor as a downstream mediator of vascular endothelial growth factor-dependent preservation of growth in the developing lung
    Authors: Gregory Seedorf, Alexander J. Metoxen, Robert Rock, Neil Markham, Sharon Ryan, Thiennu Vu et al.
    American Journal of Physiology-Lung Cellular and Molecular Physiology
  8. Novel Role for Endogenous Hepatocyte Growth Factor in the Pathogenesis of Intracranial Aneurysms
    Authors: Ricardo A. Peña-Silva, Nohra Chalouhi, Lauren Wegman-Points, Muhammad Ali, Ian Mitchell, Gary L. Pierce et al.
    Hypertension
  9. Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinoma
    Authors: Erlmeier, M;Mikuteit, M;Zsch�bitz, S;Autenrieth, M;Weichert, W;Hartmann, A;Steffens, S;Erlmeier, F;
    BMC urology
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  10. Hepatocyte growth factor derived from senescent cells attenuates cell competition-induced apical elimination of oncogenic cells
    Authors: N Igarashi, K Miyata, TM Loo, M Chiba, A Hanyu, M Nishio, H Kawasaki, H Zheng, S Toyokuni, S Kon, K Moriyama, Y Fujita, A Takahashi
    Oncogene, 2022-07-18;13(1):4157.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  11. E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects
    Authors: S Sharma, T Watanabe, T Nishimoto, T Takihara, L Mlakar, XX Nguyen, M Sanderson, Y Su, RA Chambers, C Feghali-Bo
    JCI Insight, 2021-12-22;6(24):.
    Species: Mouse
    Sample Types: BALF
    Applications: Western Blot
  12. Local administration of anti-hepatocyte growth factor-neutralizing antibody reverts naturally occurring periodontitis
    Authors: Y Yamaguchi, M Ohshima
    Journal of oral biosciences, 2021-07-22;0(0):.
    Species: Human
    Sample Types: Collagen gel
    Applications: Neutralization
  13. High hepatocyte growth factor expression in primary tumor predicts better overall survival in male breast cancer
    Authors: SQ Qiu, J van Rooije, HH Nienhuis, B van der Ve, H Timmer-Bos, E van Leeuwe, AME Walenkamp, CHM van Deurze, GH de Bock, EGE de Vries, CP Schröder
    Breast Cancer Res., 2020-03-18;22(1):30.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC
  14. Blocking the proteolytic activity of zymogen matriptase�with antibody-based inhibitors
    Authors: T Tamberg, Z Hong, D Schepper, S Skovbjerg, DM Dupont, L Vitved, CR Schar, K Skjoedt, LK Vogel, JK Jensen
    J. Biol. Chem., 2018-11-08;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  15. Coronary stents with inducible VEGF/HGF-secreting UCB-MSCs reduced restenosis and increased re-endothelialization in a swine model
    Authors: HK Chang, PH Kim, DW Kim, HM Cho, MJ Jeong, DH Kim, YK Joung, KS Lim, HB Kim, HC Lim, DK Han, YJ Hong, JY Cho
    Exp. Mol. Med., 2018-09-03;50(9):114.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  16. Priming with FGF2 stimulates human dental pulp cells to promote axonal regeneration and locomotor function recovery after spinal cord injury
    Authors: K Nagashima, T Miwa, H Soumiya, D Ushiro, T Takeda-Kaw, N Tamaoki, S Ishiguro, Y Sato, K Miyamoto, T Ohno, M Osawa, T Kunisada, T Shibata, KI Tezuka, S Furukawa, H Fukumitsu
    Sci Rep, 2017-10-18;7(1):13500.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  17. Matriptase regulates c-Met mediated proliferation and invasion in inflammatory breast cancer
    Authors: GL Zoratti, LM Tanabe, TE Hyland, MJ Duhaime, É Colombo, R Leduc, E Marsault, MD Johnson, CY Lin, J Boerner, JE Lang, K List
    Oncotarget, 2016-09-06;7(36):58162-58173.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  18. Targeting matriptase in breast cancer abrogates tumour progression via impairment of stromal-epithelial growth factor signalling.
    Authors: Zoratti G, Tanabe L, Varela F, Murray A, Bergum C, Colombo E, Lang J, Molinolo A, Leduc R, Marsault E, Boerner J, List K
    Nat Commun, 2015-04-15;6(0):6776.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  19. Spontaneous genomic alterations in a chimeric model of colorectal cancer enable metastasis and guide effective combinatorial therapy.
    Authors: Zhou Y, Rideout W, Bressel A, Yalavarthi S, Zi T, Potz D, Farlow S, Brodeur J, Monti A, Reddipalli S, Xiao Q, Bottega S, Feng B, Chiu M, Bosenberg M, Heyer J
    PLoS ONE, 2014-08-27;9(8):e105886.
    Species: Mouse
    Sample Types: Whole Tissue
    Applications: IHC
  20. Combined targeting of mTOR and c-MET signaling pathways for effective management of epithelioid sarcoma.
    Authors: Imura, Yoshinor, Yasui, Hirohiko, Outani, Hidetats, Wakamatsu, Toru, Hamada, Kenichir, Nakai, Takaaki, Yamada, Shutaro, Myoui, Akira, Araki, Nobuhito, Ueda, Takafumi, Itoh, Kazuyuki, Yoshikawa, Hideki, Naka, Norifumi
    Mol Cancer, 2014-08-07;13(0):185.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  21. Activated platelets interfere with recruitment of mesenchymal stem cells to apoptotic cardiac cells via high mobility group box 1/Toll-like receptor 4-mediated down-regulation of hepatocyte growth factor receptor MET.
    Authors: Vogel S, Chatterjee M, Metzger K, Borst O, Geisler T, Seizer P, Muller I, Mack A, Schumann S, Buhring H, Lang F, Sorg R, Langer H, Gawaz M
    J Biol Chem, 2014-02-24;289(16):11068-82.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  22. Functional mononucleotide repeat polymorphism in the promoter region of HGF is associated with risk and malignant aggressiveness of bladder cancer.
    Authors: Chiba S, Tsuchiya N, Horikawa Y, Narita S, Inoue T, Akihama S, Saito M, Numakura K, Tsuruta H, Huang M, Satoh S, Habuchi T
    Int J Oncol, 2013-12-20;44(3):678-84.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  23. Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.
    Authors: Felix AS, Edwards RP, Stone RA
    Br. J. Cancer, 2012-05-22;106(12):2004-9.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  24. c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase.
    Authors: Szabo R, Rasmussen AL, Moyer AB
    Oncogene, 2011-01-10;30(17):2003-16.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  25. Heparanase Plays a Dual Role in Driving Hepatocyte Growth Factor (HGF) Signaling by Enhancing HGF Expression and Activity.
    Authors: Ramani VC, Yang Y, Ren Y
    J. Biol. Chem., 2010-12-03;286(8):6490-9.
    Species: Human
    Sample Types: Cell Culture Supernates, Whole Tissue
    Applications: IHC-P, Immunoprecipitation
  26. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment.
    Authors: Vermeulen L, De Sousa E Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, Tuynman JB, Todaro M, Merz C, Rodermond H, Sprick MR, Kemper K, Richel DJ, Stassi G, Medema JP
    Nat. Cell Biol., 2010-04-25;12(5):468-76.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC, Neutralization
  27. Alternative proteolytic processing of hepatocyte growth factor during wound repair.
    Authors: Buchstein N, Hoffmann D, Smola H, Lang S, Paulsson M, Niemann C, Krieg T, Eming SA
    Am. J. Pathol., 2009-04-23;174(6):2116-28.
    Species: Human
    Sample Types: Tissue Secretion
    Applications: Western Blot
  28. Endogenous hepatocyte growth factor is a niche signal for subventricular zone neural stem cell amplification and self-renewal.
    Authors: Nicoleau C, Benzakour O, Agasse F, Thiriet N, Petit J, Prestoz L, Roger M, Jaber M, Coronas V
    Stem Cells, 2009-02-01;0(0):.
    Species: Canine, Mouse, Rat
    Sample Types: In Vivo, Whole Cells
    Applications: Neutralization
  29. IFATS Series: FGF-2-induced HGF Secretion By Adipose-Derived Stromal Cells Inhibits Post-Injury Fibrogenesis Through A JNK-Dependent Mechanism.
    Authors: Suga H, Eto H, Shigeura T, Inoue K, Aoi N, Kato H, Nishimura S, Manabe I, Gonda K, Yoshimura K
    Stem Cells, 2009-01-01;0(0):.
    Species: Mouse
    Sample Types: In Vivo, Tissue Homogenates, Whole Tissue
    Applications: IHC-P, Neutralization, Western Blot
  30. Bronchial epithelial cell growth regulation in fibroblast cocultures: the role of hepatocyte growth factor.
    Authors: Skibinski G, Elborn JS, Ennis M
    Am. J. Physiol. Lung Cell Mol. Physiol., 2007-03-23;293(1):L69-76.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  31. Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration.
    Authors: Giacobini P, Messina A, Wray S, Giampietro C, Crepaldi T, Carmeliet P, Fasolo A
    J. Neurosci., 2007-01-10;27(2):431-45.
    Species: Mouse
    Sample Types: Tissue Homogenates, Whole Tissue
    Applications: IHC, Neutralization, Western Blot
  32. Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1.
    Authors: Kawai A, Naito N, Ouchida M, Beppu Y
    Cancer Lett., 2004-02-10;204(1):105-13.
    Species: Human
    Sample Types: Whole Cells, Whole Tissue
    Applications: ICC, IHC
  33. Hepatocyte growth factor in polymorphonuclear leukocytes is increased in patients with systemic inflammatory response syndrome.
    Authors: Matsushima A, Ogura H, Koh T, Fujita K, Yoshiya K, Sumi Y, Hosotsubo H, Kuwagata Y, Tanaka H, Shimazu T, Sugimoto H
    J Trauma, 2004-02-01;56(2):259-64.
    Species: Human
    Sample Types: Cell Culture Supernates
    Applications: Western Blot
  34. Hepatocyte growth factor secreted by bone marrow stem cell reduce ER stress and improves repair in alveolar epithelial II cells
    Authors: Izabela Nita, Katrin Hostettler, Luca Tamo, Michaela Medová, Giuseppe Bombaci, Jun Zhong et al.
    Scientific Reports
  35. The Distribution of Vascular Endothelial Growth Factor (VEGF), Human Beta-Defensin-2 (HBD-2), and Hepatocyte Growth Factor (HGF) in Intra-Abdominal Adhesions in Children under One Year of Age
    Authors: Anna Junga, Māra Pilmane, Zane Ābola, Olafs Volrāts
    The Scientific World Journal
  36. Influence of Human Platelet Lysate on Extracellular Matrix Deposition and Cellular Characteristics in Adipose-Derived Stem Cell Sheets
    Authors: Nai-Chen Cheng, Yuan-Kun Tu, Ning-Hsu Lee, Tai-Horng Young
    Frontiers in Cell and Developmental Biology
  37. Therapeutic Potential of Human Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells in Mice with Lethal Fulminant Hepatic Failure
    Authors: Mohsen Moslem, Mojtaba Rezazadeh Valojerdi, Behshad Pournasr, Ahad Muhammadnejad, Hossein Baharvand
    Cell Transplantation
  38. VEGF, FLT3 ligand, PlGF and HGF can substitute for M-CSF to induce human osteoclast formation: implications for giant cell tumour pathobiology
    Authors: Richard M Taylor, Takeshi G Kashima, Helen J Knowles, Nicholas A Athanasou
    Laboratory Investigation

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs
Loading...

Reviews for Human HGF Antibody

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human HGF Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human HGF Antibody
By Anonymous on 04/01/2021
Application: IHC Sample Tested: Breast tissue Species: Human

primary antibody concentration is 1 to 500 dilution.